Protease-degradable PEG-maleimide Coating with On-demand Release of IL-1Ra to Improve Tissue Response to Neural Electrodes

Overview

Journal Biomaterials

Specialty Biomedical Engineering

Date 2015 Jan 25

PMID 25617126

Citations 23

Authors

Stacie M Gutowski

James T Shoemaker

Kellie L Templeman

Yang Wei

Robert A Latour Jr

Ravi V Bellamkonda

Michelle C LaPlaca

Andres J Garcia

Affiliations

Soon will be listed here.

Abstract

Neural electrodes are an important part of brain-machine interface devices that can restore functionality to patients with sensory and movement disorders. Chronically implanted neural electrodes induce an unfavorable tissue response which includes inflammation, scar formation, and neuronal cell death, eventually causing loss of electrode function. We developed a poly(ethylene glycol) hydrogel coating for neural electrodes with non-fouling characteristics, incorporated an anti-inflammatory agent, and engineered a stimulus-responsive degradable portion for on-demand release of the anti-inflammatory agent in response to inflammatory stimuli. This coating reduces in vitro glial cell adhesion, cell spreading, and cytokine release compared to uncoated controls. We also analyzed the in vivo tissue response using immunohistochemistry and microarray qRT-PCR. Although no differences were observed among coated and uncoated electrodes for inflammatory cell markers, lower IgG penetration into the tissue around PEG+IL-1Ra coated electrodes indicates an improvement in blood-brain barrier integrity. Gene expression analysis showed higher expression of IL-6 and MMP-2 around PEG+IL-1Ra samples, as well as an increase in CNTF expression, an important marker for neuronal survival. Importantly, increased neuronal survival around coated electrodes compared to uncoated controls was observed. Collectively, these results indicate promising findings for an engineered coating to increase neuronal survival and improve tissue response around implanted neural electrodes.

Citing Articles

Advancing the interfacing performances of chronically implantable neural probes in the era of CMOS neuroelectronics.

Perna A, Angotzi G, Berdondini L, Ribeiro J Front Neurosci. 2023; 17:1275908.

PMID: 38027514 PMC: 10644322. DOI: 10.3389/fnins.2023.1275908.

Differential expression of genes involved in the chronic response to intracortical microelectrodes.

Song S, Druschel L, Ricky Chan E, Capadona J Acta Biomater. 2023; 169:348-362.

PMID: 37507031 PMC: 10528922. DOI: 10.1016/j.actbio.2023.07.038.

Biopolymeric Coatings for Local Release of Therapeutics from Biomedical Implants.

Talebian S, Mendes B, Conniot J, Farajikhah S, Dehghani F, Li Z Adv Sci (Weinh). 2023; 10(12):e2207603.

PMID: 36782094 PMC: 10131825. DOI: 10.1002/advs.202207603.

Development of a Slow-Degrading Polymerized Curcumin Coating for Intracortical Microelectrodes.

Ziemba A, Woodson M, Funnell J, Wich D, Balouch B, Rende D ACS Appl Bio Mater. 2023; 6(2):806-818.

PMID: 36749645 PMC: 11366415. DOI: 10.1021/acsabm.2c00969.

A Soft Zwitterionic Hydrogel as Potential Coating on a Polyimide Surface to Reduce Foreign Body Reaction to Intraneural Electrodes.

Gori M, Giannitelli S, Vadala G, Papalia R, Zollo L, Sanchez M Molecules. 2022; 27(10).

PMID: 35630604 PMC: 9147366. DOI: 10.3390/molecules27103126.

References

Leung B, Biran R, Underwood C, Tresco P . Characterization of microglial attachment and cytokine release on biomaterials of differing surface chemistry. Biomaterials. 2008; 29(23):3289-97. DOI: 10.1016/j.biomaterials.2008.03.045. View

Spataro L, Dilgen J, Retterer S, Spence A, Isaacson M, Turner J . Dexamethasone treatment reduces astroglia responses to inserted neuroprosthetic devices in rat neocortex. Exp Neurol. 2005; 194(2):289-300. DOI: 10.1016/j.expneurol.2004.08.037. View

Hoffman A . Non-fouling surface technologies. J Biomater Sci Polym Ed. 1999; 10(10):1011-4. DOI: 10.1163/156856299x00658. View

Lebedev M, Nicolelis M . Brain-machine interfaces: past, present and future. Trends Neurosci. 2006; 29(9):536-46. DOI: 10.1016/j.tins.2006.07.004. View

Wadhwa R, Lagenaur C, Cui X . Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode. J Control Release. 2005; 110(3):531-41. DOI: 10.1016/j.jconrel.2005.10.027. View

Anderson S, Lin C, Kuntzler D, Anseth K . The performance of human mesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels. Biomaterials. 2011; 32(14):3564-74. PMC: 3085912. DOI: 10.1016/j.biomaterials.2011.01.064. View

Phelps E, Enemchukwu N, Fiore V, Sy J, Murthy N, Sulchek T . Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery. Adv Mater. 2011; 24(1):64-70, 2. PMC: 3517145. DOI: 10.1002/adma.201103574. View

Tauro J, Gemeinhart R . Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjug Chem. 2005; 16(5):1133-9. DOI: 10.1021/bc0501303. View

Taub A, Hogri R, Magal A, Mintz M, Shacham-Diamand Y . Bioactive anti-inflammatory coating for chronic neural electrodes. J Biomed Mater Res A. 2012; 100(7):1854-8. DOI: 10.1002/jbm.a.34152. View

10.

Potter K, Buck A, Self W, Capadona J . Stab injury and device implantation within the brain results in inversely multiphasic neuroinflammatory and neurodegenerative responses. J Neural Eng. 2012; 9(4):046020. DOI: 10.1088/1741-2560/9/4/046020. View

11.

Zhang M, Desai T, Ferrari M . Proteins and cells on PEG immobilized silicon surfaces. Biomaterials. 1998; 19(10):953-60. DOI: 10.1016/s0142-9612(98)00026-x. View

12.

Bracher M, Bezuidenhout D, Lutolf M, Franz T, Sun M, Zilla P . Cell specific ingrowth hydrogels. Biomaterials. 2013; 34(28):6797-803. DOI: 10.1016/j.biomaterials.2013.05.057. View

13.

Manicone A, McGuire J . Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol. 2007; 19(1):34-41. PMC: 2235912. DOI: 10.1016/j.semcdb.2007.07.003. View

14.

Zhong Y, Bellamkonda R . Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. Brain Res. 2007; 1148:15-27. PMC: 1950487. DOI: 10.1016/j.brainres.2007.02.024. View

15.

Rosenberg G . Matrix metalloproteinases in brain injury. J Neurotrauma. 1995; 12(5):833-42. DOI: 10.1089/neu.1995.12.833. View

16.

Klaver C, Caplan M . Bioactive surface for neural electrodes: decreasing astrocyte proliferation via transforming growth factor-beta1. J Biomed Mater Res A. 2007; 81(4):1011-6. DOI: 10.1002/jbm.a.31153. View

17.

Ferguson T, Muir D . MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci. 2000; 16(2):157-67. DOI: 10.1006/mcne.2000.0859. View

18.

Mercanzini A, Reddy S, Velluto D, Colin P, Maillard A, Bensadoun J . Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. J Control Release. 2010; 145(3):196-202. DOI: 10.1016/j.jconrel.2010.04.025. View

19.

Reza Abidian M, Corey J, Kipke D, Martin D . Conducting-polymer nanotubes improve electrical properties, mechanical adhesion, neural attachment, and neurite outgrowth of neural electrodes. Small. 2010; 6(3):421-9. PMC: 3045566. DOI: 10.1002/smll.200901868. View

20.

Pierce A, Sommakia S, Rickus J, Otto K . Thin-film silica sol-gel coatings for neural microelectrodes. J Neurosci Methods. 2009; 180(1):106-10. DOI: 10.1016/j.jneumeth.2009.02.008. View